Leucadia National Corporation And Jefferies Group, Inc. Announce Management Conference Call To Discuss Merger Agreement

Leucadia National Corporation (NYSE: LUK) and Jefferies Group, Inc. (NYSE: JEF) announced today that they will hold a conference call with management at 9:00 AM Eastern today, November 12, 2012, to discuss their publicly announced merger agreement.

Participants on the call will include: Richard B. Handler, Chairman and Chief Executive Officer of Jefferies; Brian P. Friedman, Executive Committee Chairman of Jefferies; Peregrine (“Peg”) Broadbent, Chief Financial Officer of Jefferies; Joe Steinberg, President of Leucadia; Justin Wheeler, Chief Operating Officer of Leucadia; and Joe Orlando, Chief Financial Officer of Leucadia.

Investors and securities industry professionals may access the management discussion by calling (877) 710-9938 or (702) 928-7183. A one-week replay of the call will also be available at (855) 859-2056 or (404) 537-3406 (conference ID #70517742).

Leucadia National Corporation (NYSE: LUK) is a diversified holding company engaged through its consolidated subsidiaries in a variety of businesses, including beef processing, manufacturing, gaming entertainment, real estate activities, medical product development and winery operations. Leucadia also has a significant equity interest in Jefferies Group, Inc., and owns equity interests in operating businesses including a commercial mortgage origination and servicing business.

Jefferies Group, Inc. (NYSE: JEF), the global investment banking firm focused on serving clients for over 50 years, is a leader in providing insight, expertise and execution to investors, companies and governments. The firm provides a full range of investment banking, sales, trading, research and strategy across the spectrum of equities, fixed income, foreign exchange, futures and commodities, and also select asset and wealth management strategies, in the Americas, Europe and Asia.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121112005797/en/
Copyright Business Wire 2010

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback